XML 82 R71.htm IDEA: XBRL DOCUMENT v3.7.0.1
(LOSS) EARNINGS PER SHARE - Schedule of (Loss) Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Earnings Per Share [Abstract]        
Net (loss) income attributable to Valeant Pharmaceuticals International, Inc. $ (38) $ (302) $ 590 $ (676)
Basic weighted-average number of common shares outstanding (in shares) 350.1 345.0 350.0 344.9
Diluted effect of stock options, RSUs and other (in shares) 0.0 0.0 0.9 0.0
Diluted weighted-average number of common shares outstanding (in shares) 350.1 345.0 350.9 344.9
(Loss) earnings per share attributable to Valeant Pharmaceuticals International, Inc.:        
Basic (in usd per share) $ (0.11) $ (0.88) $ 1.69 $ (1.96)
Diluted (in usd per share) $ (0.11) $ (0.88) $ 1.68 $ (1.96)